‘Diabetes Risk’

Diabetes Risk

Wednesday, March 17th, 2010

The Anaes recommends screening people over age 45 with at least one marker of diabetes risk outlined below:

  • Non-Caucasian origin and / or migrant
  • Markers of metabolic syndrome
  • Overweight measured from BMI, defined as> 28 kg / m²
  • Hypertension (systolic blood pressure> 140 mmHg and / or diastolic blood pressure> 90 mmHg and / or treated hypertension)
  • HDL cholesterol <0.35 g / L (0.9 mmol / L) and / or triglycerides> 2 g / L (2.3 mmol / L) and / or treated dyslipidemia;

History:

No gestational diabetes or children with birth weight over 4 kg;

Tags: , , ,
Posted in Diabetes Induced | No Comments »

Diabetes Mellitus Information

Friday, February 19th, 2010

Diabetes Mellitus in the Elderly keeps you up-to-date with the latest information concerning the treatment and understanding of conditions that lead to diabetes mellitus. Discussing the multi-organ involvement of this disease and the contingencies of a wholly effective treatment, this book explains both positive and negative attributes and reactions to tested methods. From Diabetes Mellitus in the Elderly, you’ll receive current facts and data that will help you offer the best care to the growing number of elderly patients afflicted with this disorder.

Offering you a review of studies relating to various aspects of the disease, Diabetes Mellitus in the Elderly discusses innovative information that will assist you in your practice, including:

  • genetic and polygenic links to type 2 diabetes mellitus (2 DM)
  • studies indicating the correlation between increased visceral body fat and old age and hyperinsulinemia, impaired glucose tolerance (IGT), and diabetes mellitus
  • mechanisms that increase the risk of diabetes, such as insulin resistance involving skeletal muscle and malfunctioning of the liver and B-cells from the pancreas that disrupt glucose homeostasis
  • data supporting the importance of strict glycemic control, goals of glycemic control, choice of oral agents, insulin regiments, and oral agent/insulin therapy combinations in the elderly
  • effectiveness and performance of insulin products, such as sulfonylureas, alpha-glucosidase inhibitors, biguanides, and thiozolidinediones
  • European studies that show acarbose may reduce glycemic fluctuations, insulin dosage, and episodes of nocturnal hypoglycemia

Much of the data examined in this book offers you and your colleagues ideas for future research and contains implications for more effective treatments. Complete with charts, tables, and graphs, Diabetes Mellitus in the Elderly will inform you of new developments in the field and help you decide upon the most effective methods of treatment for your patients.

Tags: , , , , , ,
Posted in Diabetes Control | No Comments »

Diabetes and Nutrition

Saturday, February 13th, 2010

Living Diabetes and Nutrition: Nutrition and the Prevention scored minds

For the second year running at the CNIT Paris La Defense, the Hall of diabetes showed the growing interest of the public for “eat” and nutrition. The exhibition “Stop complications” and “Yarious pleasures” also met with great success, while new visitors have discovered the Show aisles this year.

Roundtable Taste and Health: Put one in your head Living diabetes! Success never denied, the conferences of the show always attracts many people. To mention one, the conference Taste and Health “, with the presence of the Great Chef Olivier Roellinger, has particularly attracted the public. A roundtable conference where we learned that balanced flavors and dishes go well together, and that eating well is the beginning of health!

Tags: , , , ,
Posted in Diabetes Nutrition | No Comments »

Injections Insulin

Friday, February 12th, 2010

Diabetic patients, diagnosed with type 1 diabetes have been able to stop injecting insulin through treatment with stem cells. The tests, conducted by a team of American and Brazilian scientists, were conducted on 15 patients recently diagnosed with the disease, they had to undergo immunosuppressive therapy and were transfused with stem cells from their blood.

14 of 15 volunteers have not resorted to injections of insulin – some for several years – after treatment. Indeed one patient was able to dispense injections for 35 months while 4 other patients would be provided for at least 21 months. The treatment was effective immediately after the transfusion of stem cells for 11 of the 15 volunteers who were able to dispense with insulin injections.

This form of therapy is known as transplant (or grafting) of autologous stem cells. She has already shown encouraging for the treatment of diseases such as rheumatoid arthritis, Crohn’s disease or lupus.

Tags: , , , , ,
Posted in Diabetes and Insulin | No Comments »